Abstract

Persistent COVID is a symptomatic disease involving multiple organs which affects patients who have had COVID-19 and who continue to have symptoms (asthenia, arthralgia, myalgia, headache, dyspnea, cough, chest pain, dysphonia) for more than 4-12 weeks after infection. Its presentation is independent of the severity of the acute COVID-19 phase. It is predominant in middle-aged women. Symptoms frequently fluctuate. It can progress in the form of flare-ups and cannot be explained by an alternative underlying pathology. The incidence of persistent COVID is estimated to be about 10% of those infected. In addition to this symptomatic disease, it is possible that survivors of COVID-19 pneumonia may present with lung sequelae. It is probable that a high number of patients who have had COVID-19 pneumonia will require specialized follow-up by the pulmonology department after overcoming the acute phase. Different algorithms are being established to ensure proper follow-up for these patients.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.